Profile: Magellan Health Inc (MGLN.O)
12 Dec 2017
Magellan Health, Inc., incorporated on August 11, 1969, is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. The Company is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. The Company provides services to health plans and other managed care organizations (MCOs), employers, labor unions, various military and governmental agencies and third party administrators (TPAs).
The Company's Healthcare segment includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). These special populations include individuals with serious mental illness (SMI), dual eligibles, long-term services and supports, and other populations with complex healthcare needs. The Company's coordination and management of these healthcare services are provided through its network of medical and behavioral health professionals, clinics, hospitals and ancillary service providers.
The Healthcare segment's commercial division serves a range of customers, with services, inclusive of special population management, provided under contracts with health plans and accountable care organizations for some or all of their commercial, Medicaid and Medicare members, as well as with employers. The government division contracts with local, state and federal governmental agencies to provide services to recipients under Medicaid, Medicare and other government programs. The Company provides its management services primarily through risk-based products, where the Company assumes all or a substantial portion of the responsibility for the cost of providing treatment services in exchange for a fixed per member per month fee, and administrative services only (ASO) products, where the Company provides services, such as utilization review, claims administration and/or provider network management, but does not assume responsibility for the cost of the treatment services.
The Company's Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Pharmacy Management segment's services include pharmacy benefit management (PBM) services, pharmacy benefit administration (PBA) for state Medicaid and other government sponsored programs, pharmaceutical dispensing operations, clinical and formulary management programs, medical pharmacy management programs, and programs for the integrated management of specialty drugs across both the medical and pharmacy benefit that treat complex conditions, regardless of site of service, method of delivery, or benefit reimbursement. Pharmacy Management segment's services are provided under contracts with health plans, employers, MCOs, state Medicaid programs, Medicare Part D and other government agencies, and includes risk-based and fee-for-service (FFS) arrangements. In addition, Pharmacy Management has subcontract arrangements to provide PBM services for certain Healthcare customers.
The Corporate segment of the Company consists primarily of operational support functions, such as sales and marketing and information technology. The Corporate segment also includes corporate support functions, such as executive, finance and human resources.
Magellan Health Inc
4800 N Scottsdale Rd Ste 4400
SCOTTSDALE AZ 85251-7680
Company Web Links
- BRIEF-Magellan Health reports qtrly earnings per share $1.32
- BRIEF-Magellan Health Inc receives regulatory approvals to acquire Senior Whole Health
- BRIEF-Magellan Health announces closing of $400 million of 4.40 percent senior notes due 2024
- BRIEF-Magellan Health priced public offering of $400 mln aggregate principal amount of 4.4 pct senior notes due 2024 - SEC Filing
- BRIEF-Magellan Health qtrly earnings per share $ 0.23